75%Confidence
0Views
FDASource
2026-04-14Date
Summary
Amerisource Health Services recalls Meclizine Tablets due to failed specifications, indicating potential quality lapses in distributed products. This could affect the distributor's reliability and lead to lost contracts with healthcare providers.
Actionable: Review Amerisource's quality control processes for other distributed drugs.
AI Confidence: 75%
Data Points
firmAmerisource Health Services LLC
classificationClass II
statusOngoing
distributionU.S. Nationwide
productMeclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Dis
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now